These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 139194)

  • 1. A quantitative rotational model for studying serotonergic function in the rat.
    Jacobs BL; Simon SM; Ruimy DD; Trulson ME
    Brain Res; 1977 Mar; 124(2):271-81. PubMed ID: 139194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of serotonin on turning and sterotypy induced by apomorphine.
    Baldessarini RJ; Amatruda TT; Griffith FF; Gerson S
    Brain Res; 1975 Jul; 93(1):158-63. PubMed ID: 124619
    [No Abstract]   [Full Text] [Related]  

  • 4. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of drug-induced rotation in rats lesioned in the medial forebrain bundle with 5,6-dihydroxytryptamine or 6-hydroxydopamine.
    Pieri M; Pieri L; Saner A; Da Prada M; Haefely W
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):118-30. PubMed ID: 127559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling.
    Waddington JL; Crow TJ
    Brain Res; 1979 Feb; 161(2):371-6. PubMed ID: 310332
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoaminergic mechanisms of stimulation-produced analgesia.
    Akil H; Liebeskind JC
    Brain Res; 1975 Aug; 94(2):279-96. PubMed ID: 125141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized rotometer apparatus for recording circling behavior.
    Etemadzadeh E; Koskinen L; Kaakkola S
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):399-407. PubMed ID: 2501597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between yawning behavior and central serotonergic neuronal system in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):667-72. PubMed ID: 2957600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotational responses to serotonergic and dopaminergic agonists after unilateral dihydroxytryptamine lesions of the medial forebrain bundle: co-operative interactions of serotonin and dopamine in neostriatum.
    Waddington JL; Crow TJ
    Life Sci; 1979 Oct; 25(15):1307-14. PubMed ID: 316093
    [No Abstract]   [Full Text] [Related]  

  • 15. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
    Bagga V; Dunnett SB; Fricker RA
    Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proportionate loss of L-3,4-dihydroxyphenylalanine and L-5-hydroxttryptophan decarboxylating activity in rat central nervous system following intracisternal administration of 5, 6-dihydroxytryptamine or 6-hydroxydopamine.
    Dairman W; Horst WD; Marchelle ME; Bautz G
    J Neurochem; 1975 Apr; 24(4):619-23. PubMed ID: 1079044
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
    Trulson ME; Eubanks EE; Jacobs BL
    J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of noradrenaline in motor activity as shown by rotational behaviour after unilateral lesions of the locus coeruleus.
    Donaldson IM; Dolphin A; Jenner P; Marsden CD; Pycock C
    Brain; 1976 Sep; 99(3):427-46. PubMed ID: 1000281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serotonin in the apomorphine-induced increase of adrenomedullary ornithine decarboxylase activity.
    Almazan G; Pacheco P; Sourkes TL
    Brain Res; 1982 Sep; 248(2):285-91. PubMed ID: 6215971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.